Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration.
Cell transplantation is a promising, still novel, potentially therapeutic approach for the treatment of heart diseases. Clinical applications require generation of large number of donor cells. Embryonic stem (ES) cells are capable of self-renewal apparently in an unlimited fashion, in vitro. Theoretically, they can differentiate into any cell type required for cell transplantation, including cardiac myocytes. Diverse growth factors have been implicated in programming diverse cellular processes, including development of the embryonic heart, ES cell self-renewal, and cardiac myocyte differentiation from ES cells. This review addresses the current understanding of the role of growth factors in the differentiation of cardiac myocytes from ES-embryoid body cell systems in vitro as well as cardiac regeneration in vivo.
Singla
Dinender K
DK
Department of Medicine, Vascular Biology Unit, and Cardiovascular Research Institute, University of Vermont, Colchester, VT 05446, USA. Dinender.Kumar@uvm.edu
Sobel
Burton E
BE
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D006133:Growth Substances / Q000502:physiology*; D032342:Muscle Cells / Q000166:cytology*
D006133:Growth Substances